|
Name |
Isobutyl hexanoate
|
Molecular Formula | C10H20O2 | |
IUPAC Name* |
2-methylpropyl hexanoate
|
|
SMILES |
CCCCCC(=O)OCC(C)C
|
|
InChI |
InChI=1S/C10H20O2/c1-4-5-6-7-10(11)12-8-9(2)3/h9H,4-8H2,1-3H3
|
|
InChIKey |
UXUPPWPIGVTVQI-UHFFFAOYSA-N
|
|
Synonyms |
Isobutyl hexanoate; 105-79-3; Isobutyl caproate; 2-METHYLPROPYL HEXANOATE; Hexanoic acid, 2-methylpropyl ester; Hexanoic acid, isobutyl ester; n-Caproic acid isobutyl ester; 2-Methyl-1-propyl caproate; FEMA No. 2202; Hexanoic Acid Isobutyl Ester; iso-Butyl n-hexanoate; 2A3X4W9GZ0; Isobutyl caproate (natural); EINECS 203-332-6; UNII-2A3X4W9GZ0; AI3-24254; Isobutylhexanoate; SCHEMBL129293; CHEMBL4647902; DTXSID0059322; ISOBUTYL HEXANOATE [FCC]; CHEBI:87421; FEMA 2202; ISOBUTYL HEXANOATE [FHFI]; hexanoic acid 2-methylpropyl ester; Isobutyl hexanoate, >=98%, FG; ZINC2041122; LMFA07010729; MFCD00048870; Isobutyl hexanoate, natural, >=95%; AKOS015904122; CS-W010767; AS-75504; FT-0627358; H0110; A895938; Q27159615; Isobutyl hexanoate; n-Caproic acid isobutyl ester; 2-Methyl-1-propyl caproate
|
|
CAS | 105-79-3 | |
PubChem CID | 7775 | |
ChEMBL ID | CHEMBL4647902 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 172.26 | ALogp: | 3.4 |
HBD: | 0 | HBA: | 2 |
Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 26.3 | Aromatic Rings: | 0 |
Heavy Atoms: | 12 | QED Weighted: | 0.452 |
Caco-2 Permeability: | -4.293 | MDCK Permeability: | 0.00002610 |
Pgp-inhibitor: | 0.044 | Pgp-substrate: | 0.002 |
Human Intestinal Absorption (HIA): | 0.003 | 20% Bioavailability (F20%): | 0.147 |
30% Bioavailability (F30%): | 0.488 |
Blood-Brain-Barrier Penetration (BBB): | 0.912 | Plasma Protein Binding (PPB): | 86.74% |
Volume Distribution (VD): | 0.65 | Fu: | 13.72% |
CYP1A2-inhibitor: | 0.924 | CYP1A2-substrate: | 0.396 |
CYP2C19-inhibitor: | 0.464 | CYP2C19-substrate: | 0.695 |
CYP2C9-inhibitor: | 0.543 | CYP2C9-substrate: | 0.846 |
CYP2D6-inhibitor: | 0.01 | CYP2D6-substrate: | 0.072 |
CYP3A4-inhibitor: | 0.059 | CYP3A4-substrate: | 0.221 |
Clearance (CL): | 11.045 | Half-life (T1/2): | 0.836 |
hERG Blockers: | 0.024 | Human Hepatotoxicity (H-HT): | 0.032 |
Drug-inuced Liver Injury (DILI): | 0.185 | AMES Toxicity: | 0.01 |
Rat Oral Acute Toxicity: | 0.121 | Maximum Recommended Daily Dose: | 0.014 |
Skin Sensitization: | 0.828 | Carcinogencity: | 0.309 |
Eye Corrosion: | 0.97 | Eye Irritation: | 0.983 |
Respiratory Toxicity: | 0.245 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC000718 | 0.641 | D0AY9Q | 0.370 | ||||
ENC001015 | 0.564 | D01QLH | 0.317 | ||||
ENC000645 | 0.558 | D0G2KD | 0.306 | ||||
ENC000235 | 0.556 | D00MLW | 0.303 | ||||
ENC000231 | 0.525 | D0H2YX | 0.278 | ||||
ENC000726 | 0.525 | D05PLH | 0.274 | ||||
ENC000371 | 0.514 | D0FD0H | 0.273 | ||||
ENC000253 | 0.512 | D0ZK8H | 0.268 | ||||
ENC000655 | 0.512 | D0ZI4H | 0.261 | ||||
ENC000248 | 0.479 | D0Y3KG | 0.261 |